Navigation Links
Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
Date:4/5/2012

Carlos E. Prada, MD of Cincinnati Children's Hospital and James D. Weisfeld-Adams, MD of Mount Sinai School of Medicine, NY were honored as the 2012-2013 recipients of the Genzyme/ACMG Foundation Medical Genetics Training Award in Clinical Biochemical Genetics at the ACMG 2012 Annual Clinical Genetics Meeting in Charlotte, NC.

The objective of the two Genzyme/ACMG Foundation Awards is to support a national training program to encourage the recruitment and training of clinicians in the field of clinical biochemical genetics and especially in the diagnosis, management and treatment of individuals with metabolic diseases. For the first time, two awardees will be given the opportunity to participate in an in-depth clinical experience at a premier medical center with expertise and significant clinical volume in the area of biochemical genetics.

The Award grants $75,000 per year to each of two recipients selected by the ACMG Foundation through a competitive process and will provide for the sponsorship of one year of the trainees' clinical genetics subspecialty in biochemical genetics following residency.

Dr. Prada is currently undertaking a combined residency/fellowship in Pediatrics and Genetics at Cincinnati Children's Hospital Medical Center. He said, "I am very interested in clinical research of lysosomal diseases. The goal of my proposed research is to characterize imaging and serum biomarkers in individuals with MPSs with the future goal of identifying individuals at risk for cardiovascular complications and early initiation of therapies to improve outcomes." Dr. Prada completed his Doctor of Medicine at Universidad Industrial de Santander in Colombia and a Postdoctoral Research Fellowship in Cancer Research at University of California, San Diego.

The second award recipient, Dr. Weisfeld-Adams, received his medical degree from the University of Aberdeen in Scotland, and postgraduate training at the Royal Hospital for Sick Children in Glasgow, Scotland. More recently, he completed a combined residency/fellowship in Pediatrics and Medical Genetics at Mount Sinai School of Medicine in New York, and has recently been appointed to the clinical faculty at Mount Sinai. His research focuses on combined methylmalonic aciduria and homocystinuria, cbl C type (cobalamin C disease). His research aims to characterize the neuropathology of this disease, focusing in particular in the role of oxidative injury, disordered myelin biology, and hyperhomocysteinemia. An animal model of the disorder is under development, and, in a multidisciplinary collaboration with several other investigators, Dr. Weisfeld-Adams has initiated a clinical natural history study evaluating various aspects of the neurologic phenotype in a cohort of children and adults with this disease.

"The Genzyme/ACMG Foundation Clinical Genetics Award in Clinical Biochemical Genetics is critical to the development of the genetics workforce. Through this financial award we are supporting the education of those who are working to advance biochemical research and to develop new standards of practice in medical genetics in the United States which will both improve health and save lives," said R. Rodney Howell, MD, FACMG, president of the ACMG Foundation.

Since 2005, the Genzyme Corporation has generously sponsored this prestigious award, and last year they doubled their commitment for the 2012 through 2016 Fellowships. The ACMG Foundation is honored to have the Genzyme Corporation as a member of its Corporate Partners Program. For more information about the Corporate Partners Program and other ways to support the work of the ACMG Foundation, please visit www.acmgfoundation.org.


'/>"/>

Contact: Kathy Ridgely Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Related biology news :

1. Margarita Saenz, M.D. is recipient of Genzyme/ACMGF Fellowship in Biochemical Genetics
2. Ayman El-Hattab, MD is awarded the 2010 Genzyme/ACMG Foundation Genetics Fellowship
3. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
4. Entertainment Software Association Foundation awards grant to FAS for immune attack
5. National Science Foundation grants Clemson professors award to develop nanoprobes
6. Dunn Foundation gives Rice $3M for collaborative research grants
7. National Science Foundation grant expands UMCES oyster research
8. UT Southwestern researcher awarded Gates Foundation grant for novel vaccine development
9. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
10. Parkinsons Disease Foundation announces award of $150,000
11. Meyskens honored with AACR-Prevent Cancer Foundation award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... 20, 2016  Synaptics Incorporated (NASDAQ: SYNA ... today announced sampling of S1423, its newest ClearPad ... small screen applications including smartwatches, fitness trackers, and ... and rectangular shapes, as well as thick and ... moisture on screen, while wearing gloves, and supports ...
(Date:1/15/2016)... , Jan. 15, 2016 Recent publicized ... small to find new ways to ensure data security ... iOS and Android that ties ... biometrics, transforming it into a hardware authorization token. Customer ... swipe their fingerprint on their KodeKey enabled device to ...
(Date:1/13/2016)... , January 13, 2016 /PRNewswire/ ... announced the addition of the  "India ... Estimation & Forecast (2015-2020)"  report ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the addition ... Identification Market - Estimation & Forecast ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Information Management ... Web product. The upgrade represents a completely new technical foundation and is so ... offer a responsive design interface, significantly increased speed for search results, a streamlined layout ...
(Date:2/8/2016)... Feb. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that its new website has ... resource–user-centric, story-driven, knowledge-based and mobile-friendly. Visit the new ... ... ... "The goal was to reimagine ...
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical ... for a host of launch activities including the identification ... this launch activity is especially high in the oncology ... Best Practices and the Role of Medical Affairs ... companies focused on oncology therapies find better ways to ...
(Date:2/4/2016)... - New FDA action date of July 22, ... July 22, 2016   --> - ...   - Lifitegrast has the potential to be the ... signs and symptoms of dry eye disease in adults ... product approved in the U.S. in the past decade indicated for the treatment of ...
Breaking Biology Technology: